Formulations of 19-nor C3,3- disubstituted C21-n-pyrazolyl steroid and methods of use thereof

NZ835359APending Publication Date: 2026-07-31SAGE THERAPEUTICS LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ835359
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-07-20
Filing Date
2021-07-20
Publication Date
2026-07-31

Smart Images

  • Figure 00000183_0000
    Figure 00000183_0000
  • Figure 00000184_0000
    Figure 00000184_0000
  • Figure 00000184_0001
    Figure 00000184_0001
Patent Text Reader

Abstract

This invention relates to a 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) and pharmaceutical compo­sitions thereof. Also disclosed herein are methods of making the pharmaceutical compositions of the 19-nor C3,3-disubstituted C21­pyrazolyl steroid of formula (I) and methods of using the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) or crystalline solid forms, pharmaceutically acceptable salts, and pharmaceutically acceptable compositions thereof.
Need to check novelty before this filing date? Find Prior Art